Darrell Hoppes
Foot & Ankle Surgery · Harrisburg, PANPI 1255642500
Payments from drug & device makers
What this record shows
Treace Medical Concepts, Inc. accounts for 64.9% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2021 at $1,455 and has fallen 76.5% since, to $343 in 2025.
Across 75 payments — averaging $66.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$3K
- Stryker$1K
- Smith+Nephew$141
- Paratek Pharmaceuticals, Inc.$99
- DJO, LLC$84
- Melinta Therapeutics, LLC$69
- plus $320 from 9 others
What the payments were for
- Travel & lodging$2,87658%
- Food & beverage$2,11442%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 15 | $3,240 |
| Stryker | 32 | $1,037 |
| Smith+Nephew | 6 | $141 |
| Paratek Pharmaceuticals, Inc. | 3 | $99 |
| DJO, LLC | 5 | $84 |
| Melinta Therapeutics, LLC | 3 | $69 |
| Ossio Inc | 1 | $67 |
| Lifenet Health | 2 | $57 |
| Integra Lifesciences Corporation | 1 | $37 |
| Organogenesis Inc. | 2 | $37 |
| Averitas Pharma Inc. | 1 | $34 |
| Paragon 28, Inc. | 1 | $26 |
| Misonix Inc | 1 | $24 |
| GRT US Holding, Inc. | 1 | $22 |
| Nevro Corp. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$2,972
- ANCHORAGE$101
- N/A$101
How this compares
$4,990 in reported general payments places this provider in the 65th percentile of 575 foot & ankle surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 26 | $1,195 |
| Gabapentin | 52 | $654 |
| Duloxetine Hcl | 16 | $378 |
| Ciclopirox | 11 | $367 |
| Prednisone | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Harrisburg
- Allan GrossmanHarrisburg$89K
- William DecarboBelle Vernon$3.5M
- David PedowitzBryn Mawr$1.6M
- Noman SiddiquiScranton$1.3M
- Peter MangonePittsburgh$1.1M
- Stephen BrigidoBethlehem$656K
- Guido LaportaDunmore$625K
- Adam TeichmanAllentown$545K
- Thomas RocchioAllentown$524K
- Jason MillerMalvern$501K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.